Jarrett Disbrow insider trades
Open-market stock purchases and sales by Jarrett Disbrow, Chief Business Officer at Aytu Biopharma, Inc, from SEC Form 4 filings since Nov 11, 2015.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +81%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 28, 2026 | AYTU Aytu Biopharma, Inc | Bought (not open market) | — |
Companies traded
- AYTU Aytu Biopharma, Inc: 6 buys, last Jul 28, 2026